Sangamo Therapeutics Inc (NAS:SGMO)
$ 2.16 0.42 (24.14%) Market Cap: 449.76 Mil Enterprise Value: 363.62 Mil PE Ratio: 0 PB Ratio: 19.64 GF Score: 42/100

Q3 2019 Sangamo Therapeutics Inc Earnings Call Transcript

Nov 06, 2019 / 10:00PM GMT
Release Date Price: $9.46
Operator

Good afternoon, and welcome to the Sangamo Therapeutics teleconference to discuss third quarter 2019 financial results. This call is being recorded. I will now pass you over to the coordinator of this event, McDavid Stilwell, Senior Vice President of Corporate Communications and Investor Relations. You may begin.

McDavid Stilwell
Sangamo Therapeutics, Inc. - SVP of Corporate Communications & IR

Hello, and thank you for joining us. As we begin, I'd like to point out that we have posted our updated corporate presentation to our website, and we'll be referencing several of these slides today. A link to the slide presentation may be found on our website, sangamo.com, on the Events and Presentations page of the Investors and Media section of the site. I'd also like to remind everyone that the projections and forward-looking statements that we will discuss during today's conference call are based upon the information that we have available today.

Forward-looking statements include, but are not limited to, statements related to the timing and scope of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot